Anhydrosis and hyperthermia associated with treatment with topiramate;Anhidrosis e hipertermia asociadas al tratamiento con topiramato

Revista de Neurologia

Volumn 34, Issue 2, 2002, Pages 114-116

  Nieto Barrera, M ^a   Nieto Jimenez M ^a   Candau, R ^a   Ruiz del Portal, L ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Adverse effects; Anhydrosis; Hyperthermia; Refractory epilepsy; Topiramate

Indexed keywords

CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE IV; TOPIRAMATE; UNCLASSIFIED DRUG;

ADOLESCENT; ANHIDROSIS; ANTICONVULSANT THERAPY; ARTICLE; AUTONOMIC DYSFUNCTION; BODY TEMPERATURE; CHILD; CLIMATE CHANGE; CLINICAL ARTICLE; CONTROLLED STUDY; COOLING; DISEASE PREDISPOSITION; DOSE RESPONSE; ENVIRONMENTAL TEMPERATURE; EPILEPSY; FATIGUE; HUMAN; HYPERTHERMIA; SUMMER; SWEATING; THERMOREGULATION; URINE RETENTION;

EID: 0036344989     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3402.2001374     Document Type: Article

References (15)

1. Pharmacokinetic profile of topiramate in comparison with other new antiepileptic drugs
2. Preliminary observations on topiramate in pediatric epilepsies
3. The safety and adverse event profile of topiramate
4. Trastorno de la termorregulación asociado al tratamiento con topiramato
5. Topiramate monotherapy for partial onset seizures
6. Double-blind, placebo-controlled trial for topiramate as add-on therapy in patients with refractory partial seizures
7. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy
8. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200, 400 and 600 mg daily dosages
9. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600, 800 and 1,000 mg daily dosages
10. Safety of topiramate: Adverse events and relationships to dosing
11. Topiramate: Proled analysis of six placebo-controlled trials
12. Eficacia y tolerabilidad del topiramato a largo plazo en 44 niños con epilepsias rebeldes
13. Topiramate as an inhibitor of carbonic anhydrase isoenzymes
14. Topiramate and fulminant liver failure
15. Predictive value of acetylcholine stimulation testing for oligohidrosis caused by zonisamide